Proteomic Assessment of Preterm Birth
NCT01371019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5500
Last updated 2015-06-11
Summary
The purpose of this study is to to collect and store blood samples that will be utilized to develop a multimarker test to predict preterm delivery.
Conditions
Sponsors & Collaborators
-
Sera Prognostics, Inc.
lead INDUSTRY
Principal Investigators
-
Durlin E Hickok, MD, MPH · Sera Prognostics, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2014-12-31
- Completion
- 2015-04-30
Countries
- United States
Study Locations
More Related Trials
-
Microarray Expression Profiling to Identify Stereotypic mRNA Profiles in Human Parturition
NCT00342277 ·Status: COMPLETED
-
New Biomarkers Associated With the Risk of Premature Delivery.
NCT04067908 ·Status: COMPLETED ·Phase: NA
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers
NCT01009723 ·Status: UNKNOWN
-
Spontaneous Preterm Birth Marker Test
NCT03123926 ·Status: UNKNOWN
-
Precision Medicine for Preterm Birth
NCT02173210 ·Status: COMPLETED
-
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
NCT05131282 ·Status: COMPLETED
-
fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth
NCT01955148 ·Status: UNKNOWN
-
Procalcitonin and Threatened Premature Delivery
NCT01977079 ·Status: TERMINATED ·Phase: NA
-
Cell-Based Noninvasive Prenatal Testing
NCT05245266 ·Status: UNKNOWN ·Phase: NA
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
Prediction of the Onset of Term and Preterm Labour
NCT04590677 ·Status: UNKNOWN
-
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
NCT03767803 ·Status: UNKNOWN
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
NCT00572793 ·Status: COMPLETED
-
Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia
NCT00719654 ·Status: COMPLETED
-
Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM
NCT04532021 ·Status: UNKNOWN
-
Biomarkers in Obstetrical Complications
NCT03480139 ·Status: COMPLETED
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
NCT05502510 ·Status: COMPLETED
-
Threatened Preterm Birth and Time of Subsequent Delivery -a Prediction Model
NCT03796949 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189 ·Status: TERMINATED
-
Screening To Obviate Preterm Birth
NCT01868308 ·Status: COMPLETED